Main Article Content
There is an increasing public awareness that cancer in terms of increasing incidence rates and low curability become a serious problem in Tanzania. Due to limited human and physical resources in Tanzania, cancer interventions that address high incidences, curability and socio-economic impact must be given top priority. This information is often obtained in Population Based Cancer Registry (PBCR) which is not only lacking in Tanzania but its production requires relatively long period of follow-up and high cost of registration. Since establishment of effective cancer intervention is urgent, the desired information needed to accord this priority has been obtained from Hospital Based Cancer Statistics at Ocean Road Cancer Institute (ORCI). From this study, it was found that interventions of cancer of the cervix, breast, kaposi sarcoma, esophageal and head and neck has to be given high priority. It was also observed that treatment outcome for cervical cancer patients of all stages ranged between 34.2 % and 39.1% in the year 2010 and 2015 respectively. Using incidence, curability and socio-economic indices, the cancer type which require effective intervention are cancer of the cervix, breast and kaposi sarcoma. Implicitly, in the low cure rate of each detected cervical cancer in Tanzania compared to high cure rate reported in developed countries, early detection interventions and dose delivery accuracy should be improved.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submission of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, will not be published elsewhere in the same form, in English or in any other language, without the written consent of the Publisher. The Editors reserve the right to edit or otherwise alter all contributions, but authors will receive proofs for approval before publication.
Copyrights for articles published in IJIER journals are retained by the authors, with first publication rights granted to the journal. The journal/publisher is not responsible for subsequent uses of the work. It is the author's responsibility to bring an infringement action if so desired by the author.
 L.A. Torre, F. Islami, R.L. Siegel, E.M. Ward and A. Jemal, “Global cancer in women: Burden and trends”, (2017), Cancer Epidemiol Biomarkers, American Association for Cancer Research, Williams Street, Atlanta, , Prev 25(1) January 2016.
 J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, and D.M. Parkin, 2010, “Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008”, Int. J. Cancer, 127: 2893–2917.
 J.Ferley, “Latest world cancer statistics Global cancer burden rises to 14 . 1 million new cases in 2012 : Marked increase in breast cancers must be addressed”, (2013), Int. Agency Res. Cancer, World Heal. Organ, Press rele: 2012–2014.
 F. Bray, J. Ferlay, and I. Soerjomataram, “Global Cancer Statistics 2018 : GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries”, (2018), Cancer J cln. 68:394–424.
 B. Cao, F. Bray, H. Beltrán-Sánchez, O. Ginsburg, S. Soneji, and I. Soerjomataram, “Benchmarking life expectancy and cancer mortality: global comparison with cardiovascular disease 1981-2010”, (2017), Bmj 357: j2765.
 K.K. Poudel, Z. Huang , P.R. Neupane, R. Steel, and J.K. Poudel, “Hospital-Based Cancer Incidence in Nepal from 2010 to 2013 Abstract”,(2013), Nepal J. Epidemiol, NepJOL-INASP, 7: 659–665.
 J.Chen , H. Chen , J. Zhu, Y.Yang, Y. Zhang, and P. Huang, 2018 “Cancer survival in patients from a hospital-based cancer registry”, (2018), China. J. cancer , 9.
 T. Matsuda, and K. Saika, “Cancer burden in Japan based on the latest cancer statistics : need for evidence-based cancer control programs”, (2018), Ann Cancer Epidemiol, 2:2.
 T. Ngoma, R. Muwonge, J. Mwaiselage, J. Kawegere, P. Bukori, and R. Sankaranarayanan, “Evaluation of cervical visual inspection screening in Dar es Salaam, Tanzania”, Int J Gynaecol Obs, Elsevier Ireland Ltd, (2010), 109: 100–104.
 T. Ngoma, C. Kahesa, and J. Mwaiselage, “Cost-Effectiveness of Screening and Treatment for Cervical Cancer in Tanzania: Implications for other Sub-Saharan African Countries”, (2016), Value Health Reg, 10: 1–6.
 H.L. Kidanto, C.D. Kilewo, and C. Moshiro, “Cancer of the Cervix: Knowledge and Attitudes of Female Patients Admitted At Muhimbili National Hospital, Dar es Salaam”, (2002), East African Med. J, 79: 467–475.
 R. McCree, M.R. Giattas, V.V. Sahasrabuddhe, P.E. Jolly, M.Y. Martin, S.L. Usdan , C. Kohler, and N. Lisovicz, “Expanding Cervical Cancer Screening and Treatment in Tanzania: Stakeholders’ Perceptions of Structural Influences on Scale-Up”, (2015) Oncologist, 20: 621–6.
 E. Cazap, I. Magrath, T.P. Kingham, and A. Elzawawy, “Structural barriers to diagnosis and treatment of cancer in low- and middle-income countries: The urgent need for scaling up”, (2016), J. Clin. Oncol, 34: 14–19.
 F.I. Modibbo , E. Dareng, P. Bamisaye, E. Jedy-Agba, A. Adewole, L. Oyeneyin , O. Olaniyan, and C. Adebamowo , “Qualitative study of barriers to cervical cancer screening among Nigerian women”, (2016), BMJ Open, 6: e008533.